Evidence map›Paper›PMID 39452664›Full record

ReviewJournal of fungi (Basel, Switzerland)2024

State of the Field: Cytotoxic Immune Cell Responses in

Elizabeth C Okafor, Kirsten Nielsen

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of fungi (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Rapid and simultaneous detection ofFrontiers in cellular and infection microbiology · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Elizabeth C OkaforDepartment of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.ORCID 0000-0003-1495-4596
Kirsten NielsenDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis, MN 55455, USA.ORCID 0000-0002-2318-168X

Funding

Genomic Research Capacity Building for Cryptococcosis Translational StudiesR01NS118538 · NINDS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI Joel Bazira, David Bisagaya Meya · 2020 to 2026
$3.4M
TB Meningitis: Evaluating CSF Immunology to Discover Hidden Disease and Potential Immunomodulatory TherapiesR01AI162786 · NIAID · UNIVERSITY OF MINNESOTA · PI BOULWARE, DAVID R, MEYA, DAVID BISAGAYA · 2021 to 2025
$3.3M
Continuum of Immune Responses to Cryptococcus neoformansR01AI176922 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI Kirsten Nielsen · 2023 to 2026
$3.0M
National Institute of Allergy and Infectious Diseases NRSA F31AI62230National Institute of Allergy and Infectious Diseases R01AI162786National Institute of Allergy and Infectious Diseases R01AI176922NIAID NIH HHS R01 AI162786NIAID NIH HHS R01 AI176922NINDS NIH HHS R01 NS118538NINDS NIH HHS R01NS118538
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

advanced immunodeficiency virus (AIDS)CD4+ T-cellsCD8+ T-cellscryptococcal meningitisCryptococcus neoformanscytotoxic cellsfungal infectiongamma/delta T-cellshuman immunodeficiency virus (HIV)natural killer cells

Identifiers

PMID39452664
PMCPMC11508571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.